FGFR Gene Alterations
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (NCT06995677) | Tyra Biosciences, Inc | 2025-06-27 |
| Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations (NCT06915753) | Tyra Biosciences, Inc | 2025-04-24 |
| NCCH2006/MK010 Trial (FORTUNE Trial) (NCT04962867) | National Cancer Center, Japan | 2021-06-15 |
Track FGFR Gene Alterations automatically
Every clearance here is in the API, with alerts when new ones post.